TG and epilepsy: Principal diagnoses were found to co-occur with the following additional diagnoses: hypothyroidism 4.3% (N = 14) and symptomatic epilepsy 26.3% (N = 86)—the patients with these diagnoses were receiving anti-epileptic drugs and thyroid hormone supplementation, respectively.